Better Therapeutics(BTTX) - 2023 Q3 - Earnings Call Presentation

4 Obtain Commercial Payer Coverage for AspyreRx Better Therapeutics Team Mark Berman, MD Chief Financial Officer Frank Karbe President & Chief Executive Officer Diane Gomez-Thinnes Chief Commercial Officer Disclaimer Certain statements in this Presentation may be considered forward-looking statements, within the meaning of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by words such as "plan," "believe, ...